Vivaldi Coelho Rogerio
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to Vivaldi Coelho Rogerio. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CRNX | Award / Grant | 6,900 | — | — | Jun 11, 2025 | |
| VTRS | Option Exercise | 21,267 | — | — | Mar 4, 2025 | |
| CRNX | Award / Grant | 3,400 | — | — | Jun 7, 2024 | |
| 0001821323 | PRESIDENT AND CEO | Disposition | 12,169 | — | — | Aug 11, 2023 |
| 0001821323 | PRESIDENT AND CEO | Option Exercise | 5,528 | $19.24 | $106,359 | Jul 21, 2023 |
| CRNX | Award / Grant | 6,000 | — | — | Jun 16, 2023 | |
| CRNX | Purchase | 5,000 | $22.06 | $110,300 | Jun 8, 2023 | |
| 0001821323 | PRESIDENT AND CEO | Award / Grant | 50,000 | — | — | Nov 4, 2021 |
| 0001821323 | President and CEO | C | 22,222 | — | — | Dec 8, 2020 |
| 0001681689 | EVP, Chief Global Therapeutics | Disposition | 5,758 | — | — | Mar 8, 2018 |
| 0001681689 | EVP, Chief Global Therapeutics | Option Exercise | 7,114 | — | — | Feb 14, 2018 |
| 0001609351 | Chief Commercial Officer | Option Exercise | 5,000 | $7.50 | $37,500 | Jul 15, 2016 |
| 0001609351 | Chief Commercial Officer | Option Exercise | 1,000 | $3.45 | $3,450 | Apr 20, 2016 |
| 0001609351 | Chief Commercial Officer | Option Exercise | 37,333 | $7.50 | $279,998 | Oct 13, 2015 |
| 0001609351 | Chief Commercial Officer | Sale | 40,000 | $48.81 | $1,952,400 | Oct 7, 2015 |
| 0001609351 | Chief Commercial Officer | Purchase | 2,500 | $23.00 | $57,500 | Feb 4, 2015 |
| NERV | President and CEO | Purchase | 41,667 | $6.00 | $250,002 | Jul 1, 2014 |